NQO1 and early-onset autosomal dominant Alzheimer disease: For instance, a previous study demonstrated that dual BACE-1/GSK-3β inhibitors act through the inhibition of the NQO1 enzyme in order to counteract the oxidative stress in Alzheimer's disease [76].